Arvaya Healthcare Ltd - 524723 - Announcement under Regulation 30 (LODR)-Acquisition
Arvaya Healthcare acquired 100% equity of Sushodha Institute of Gastroenterology Private Limited for Rs. 15.48 crore. The acquisition, funded through a share swap, expands the company's presence in specialized gastroenterology and healthcare services.
Jul 11 2026 14:56:14
Arvaya Healthcare Ltd - 524723 - Announcement under Regulation 30 (LODR)-Issue of Securities
Arvaya Healthcare's Board approved a rights issue to raise up to Rs. 210 crore. Additionally, a preferential issue of shares worth Rs. 15.49 crore was approved to acquire 100% equity of Sushodha Institute of Gastroenterology. This fundraise supports business synergies and market expansion.
Jul 11 2026 14:53:12
Arvaya Healthcare Ltd - 524723 - Announcement under Regulation 30 (LODR)-Raising of Funds
Bijoy Hans board approved a rights issue to raise up to Rs. 210 crores from eligible equity shareholders. Concurrently, a preferential issue worth Rs. 15.49 crores was approved to fund the 100% acquisition of Sushodha Institute of Gastroenterology Private Limited (SIGPL). Both are subject to shareholder and regulatory approvals.
Jul 11 2026 14:48:59
Arvaya Healthcare Ltd - 524723 - Board Meeting Outcome for Board Meeting Dated 11 July 2026
Arvaya Healthcare board approved the acquisition of 100% equity in Sushodha Institute of Gastroenterology Private Limited for ₹15.48 crores, funded by a preferential share issue. Additionally, the board approved raising up to ₹210 crores via a rights issue to support growth.
Jul 11 2026 14:43:44
Bijoy Hans Ltd - 524723 - Announcement under Regulation 30 (LODR)-Change of Company Name
Bijoy Hans Limited has changed its name to Arvaya Healthcare Limited. This name change, approved by BSE Limited, will be effective in the exchange's records from July 13, 2026, indicating a strategic reorientation of the company's business activities.
Jul 08 2026 16:04:26
Bijoy Hans Ltd - 524723 - Announcement under Regulation 30 (LODR)-Change in Directorate
Arvaya Healthcare's Board approved the appointment of Mr. Bidari Kotresh Anilkumar as an Additional Director, designated as Executive Director. He will serve a three-year term, effective from July 4, 2026, bringing over 12 years of leadership experience in healthcare operations.
Jul 04 2026 12:14:57
Bijoy Hans Ltd - 524723 - Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th July, 2026
Arvaya Healthcare's Board appointed Mr. Bidari Kotresh Anilkumar as an Additional Director, designated as Executive Director, for a three-year term starting July 4, 2026. This appointment, based on the Nomination & Remuneration Committee's recommendation, is subject to shareholder approval.
Jul 04 2026 12:01:48
Bijoy Hans Ltd - 524723 - Board Meeting Intimation for To Consider & Appoint Mr. Bidari Kotresh Anilkumar As An Additional Director (Executive) Designated As Executive Director Of The Company.
Arvaya Healthcare will hold a Board Meeting on July 04, 2026. The key agenda is to consider the appointment of Mr. Bidari Kotresh Anilkumar as an Additional Director (Executive) for the company.
Jun 30 2026 21:44:00
Bijoy Hans Ltd - 524723 - Approval Letter For Re-Classification Of Shareholders Under Regulation 31A Of SEBI (LODR) Regulations, 2015.
Arvaya Healthcare received approval from BSE Limited for the reclassification of specific promoter group members to the public category. This reclassification maintains the promoter shareholding percentage at 30.62%, as the reclassified individuals held no shares.
Jun 29 2026 16:57:58
Read More